Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -79.92% | 4.56% | -232.03% | -3.29% | -256.57% |
| Total Depreciation and Amortization | -103.85% | -84.62% | -76.54% | 45.78% | -14.29% |
| Total Amortization of Deferred Charges | -5.99% | -8.20% | 3.73% | 16.66% | 94.70% |
| Total Other Non-Cash Items | 570.51% | 60.59% | 1,298.46% | 2,983.14% | 110.51% |
| Change in Net Operating Assets | -87.34% | 352.52% | -41.54% | 35.96% | 206.08% |
| Cash from Operations | -33.34% | 41.70% | 54.17% | 69.88% | 51.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.89% | -79.07% | -66.09% | -35.71% | -64.33% |
| Cash from Investing | -154.89% | -79.07% | -66.21% | -35.71% | -64.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.24% | -- | 1,246.32% | -- | -53.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -352.25% | -- | 4,266.47% | -- | -99.13% |
| Foreign Exchange rate Adjustments | -150.00% | -60.00% | 125.00% | -94.44% | 172.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74,627.08% | 227.80% | 320.89% | 91.18% | -100.09% |